Iqvia Holdings (IQV) Capital Expenditures Growth (1y) (2013 - 2026)
Iqvia Holdings (IQV) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.61 Bn | 209.54 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.90 Bn | 136.55 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.29 Bn | 46.09 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.72 Bn | 37.92 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.22 Bn | 37.14 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.97 Bn | 37.87 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.10 Bn | 28.93 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.20 Bn | 25.58 Bn | 1.03 Bn | 27.78% |
| 10 | Labcorp Holdings | 25.85 Bn | 24.87 Bn | 1.01 Bn | -3.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.13% |
| Mar 31, 2026 | -10.56% |
| Dec 31, 2025 | 6.10% |
| Sep 30, 2025 | -9.33% |
| Jun 30, 2025 | 5.59% |
| Mar 31, 2025 | -2.07% |
| Dec 31, 2024 | -8.38% |
| Sep 30, 2024 | 2.74% |
| Jun 30, 2024 | -10.62% |
| Mar 31, 2024 | -11.59% |
| Dec 31, 2023 | 4.68% |
| Sep 30, 2023 | -11.52% |
| Jun 30, 2023 | -0.62% |
| Mar 31, 2023 | -7.34% |
| Dec 31, 2022 | -7.07% |
| Sep 30, 2022 | 1.85% |
| Jun 30, 2022 | 11.03% |
| Mar 31, 2022 | 18.79% |
| Dec 31, 2021 | 4.55% |
| Sep 30, 2021 | 3.18% |